Article PDF
References
Swift, M. Shelman, L. & Perry, M. Cancer Res. 36, 209–215 (1976).
Athma, P. Rappaport, R. & Swift, M. Cancer Genet. Cytogenet. 92, 130–134 (1996).
FitzGerald, M.G. et al. Nature Genet. 15, 307–310(1997).
Easton, D. Int. J. Radiat. Biol. 66, S177–182 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bishop, D., Hopper, J. AT-tributable risks?. Nat Genet 15, 226 (1997). https://doi.org/10.1038/ng0397-226
Issue Date:
DOI: https://doi.org/10.1038/ng0397-226
This article is cited by
-
BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
Familial Cancer (2012)
-
Rare variants in the ATMgene and risk of breast cancer
Breast Cancer Research (2011)
-
Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background
Oncogene (2008)
-
ATM variants and cancer risk in breast cancer patients from Southern Finland
BMC Cancer (2006)
-
More breast cancer genes?
Breast Cancer Research (2001)